論文業績

 

2018

8. Tanei T, Pradipta AR, Morimoto K, Fujii M, Arata M, Ito A, Yoshida M, Saigitbatalova E, Kurbangalieva A, Ikeda JI, Morii E, Noguchi S, Tanaka K. Cascade Reaction in Human Live Tissue Allows Clinically Applicable Diagnosis of Breast Cancer Morphology. Advanced Science, in press.

doi: 10.1002/advs.201801479

 

7. Wada N, Nojima S, Tahara SI, Ohshima K, Kurashige M, Kawasaki K, Tone M, Kusumoto S, Ikeda JI, Morii E. Effect of glutamine on lymphoplasmacytic lymphoma, especially on the viewpoint of the differentiation into vulnerable subpopulation. Pathol Res Pract. 2018; 214(10):1667-1674. Aug 27. pii: S0344-0338(18)30554-5.

doi: 10.1016/j.prp.2018.08.019.

 

6. Kurashige M, Kohara M, Ohshima K, Tahara S, Hori Y, Nojima S, Wada N, Ikeda JI, Miyamura K, Ito M, Morii E. Origin of cancer-associated fibroblasts and tumor-associated macrophages in humans after sex-mismatched bone marrow transplantation. Commun Biol, 2018 Sep 3;1:131.

doi: 10.1038/s42003-018-0137-0. eCollection 2018.

 

5. Uchida G, Ito T, Ikeda J, Suzkuki T, Takenaka K, Setsuhara Y. Effect of plasma-activated medium produced by direct irradiation on cancer cell killing.

Japanese Journal of Applied Physics (2018), in press. 57, 096201

 

4. Mishima C, Kagara N, Ikeda JI, Morii E, Miyake T, Tanei T, Naoi Y, Shimoda M, Shimazu K, Kim SJ, Noguchi S. Mutational analysis of AKT1 and PIK3CA in intraductal papillomas of the breast with special reference to cellular components. Am J Pathol, 2018;188:1106-1112.

doi: 10.1016/j.ajpath.2018.01.005.

 

3. Achiha T, Arita H, Kagawa N, Murase T, Ikeda JI, Morii E, Kanemura Y, Fujimoto Y, Kishima H. Enchondromatosis-associated oligodendroglioma: case report and literature review. Brain Tumor Pathology, 2018;35:36-40.

doi: 10.1007/s10014-017-0303-y.

 

2. Park H, Ohshima K, Nojima S, Tahara S, Kurashige M, Hori Y, Okuzaki D, Wada N, Ikeda JI, Morii E. Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate. Lab Invest, 2018;98:449-461.

doi: 10.1038/s41374-017-0017-0.

 

1. Ikeda J, Tanaka H, Ishikawa K, Sakakita H, Ikehara Y, Hori M. Plasma-activated medium (PAM) kills human cancer-initiating cells. Pathol Int, 2018:68:23-30.

doi: 10.1111/pin.12617.

 

2017年以前

64. Nojima S, Susaki EA, Yoshida K, Takemoto H, Tsujimura N, Iijima S, Takachi K, Nakahara Y, Tahara S, Ohshima K, Kurashige M, Hori Y, Wada N, Ikeda JI, Kumanogoh A, Morii E, Ueda HR. CUBIC pathology: three-dimensional imaging for pathological diagnosis. Sci Rep, 2017 Aug 24;7(1):9269.

doi: 10.1038/s41598-017-09117-0.

 

63. Matsui T, Mizuno H, Sudo T, Kikuta J, Haraguchi N, Ikeda JI, Mizushima T, Yamamoto H, Morii E, Mori M, Ishii M. Non-labeling multiphoton excitation microscopy as a novel diagnostic tool for discriminating normal tissue and colorectal cancer lesions. Sci Rep, 2017 Jul 31;7:6959. 

doi:10.1038/s41598-017-07244-2

 

62. Chihara Y, Shimoda M, Hori A, Ohara A, Naoi Y, Ikeda JI, Kagara N, Tanei T, Shimomura A, Shimazu K, Kim SJ, Noguchi S. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.

Breast Cancer Res Treat, 2017 166(1):55-68.

doi: 10.1007/s10549-017-4382-6.

 

61. Wada N, Ikeda JI, Tanaka H, Sakakita H, Hori M, Ikehara Y, Morii E. Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma. Pathol Res Pract, 2017 Jul;213(7):773-777.

doi: 10.1016/j.prp.2017.04.003.

 

60. Ohshima K, Nojima S, Tahara S, Kurashige M, Hori Y, Hagiwara K, Okuzaki D, Oki S, Wada N, Ikeda JI, Kanai Y, Morii E. Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine through Decreased DEPTOR Expression in Endometrial Cancer. Sci Rep, 2017 Mar 30;7:45504.

doi: 10.1038/srep45504.

 

59. Hirose K, Okura M, Sato S, Murakami S, Ikeda JI, Noda Y, Fukuda Y, Morii E, Toyosawa S. Gnathic giant cell-rich conventional osteosarcoma with MDM2 and CDK4 gene amplification. Histopathology, 2017 Jun 70(7):1171-1173

doi: 10.1111/his.13141.

 

58. Ohno S, Ikeda JI, Naito Y, Okuzaki D, Sasakura T, Fukushima K, Nishikawa Y, Ota K, Kato Y, Wang M, Torigata K, Kasama T, Uchihashi T, Miura D, Yabuta N, Morii E, Nojima H. Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2. Sci Rep, 2016 Dec 16;6:39091.

doi: 10.1038/srep39091.

 

57. Ikeda JI, Kohara M, Tsuruta Y, Nojima S, Tahara S, Ohshima K, Kurashige M, Wada N, Morii E. Immunohistochemical analysis of the novel marginal-zone B-cell marker IRTA1 in malignant lymphoma. Hum Pathol, 2017;59:70-79.

doi: 10.1016/j.humpath.2016.09.011.

 

56. Tahara S, Nojima S, Ohshima K, Hori Y, Kurashige M, Wada N, Ikeda J, Morii E. S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the ‘MELF’ pattern. Cancer Sci, 2016;109:1345-1352.

doi: 10.1111/cas.12999.

 

55.Zhan M, Hori Y, Wada N, Ikeda J, Hata Y, Osuga K, Morii E. Angiogenic factor with G-patch and FHA domain 1 (AGGF1) expression in human vascular lesions. Acta Histochem Cytochem, 2016;49:75-81.

doi: 10.1267/ahc.15035.

 

54. Ikeda JI, Wada N, Nojima S, Tahara S, Tsuruta Y, Oya K, Morii E. ID1 upregulation and FoxO3a downregulation by Epstein-Barr virus-encoded LMP1 in Hodgkin lymphoma. Mol Clin Oncol, 2016;5:562-566.

 

53. Miyamoto K, Ikehara S, Takei H, Akimoto Y, Sakakita H, Ishikawa K, Ueda M, Ikeda J, Yamagishi M, Kim J, Yamaguchi T, Nakanishi H, Shimizu N, Hori M, Ikehara Y. Red Blood Cell Coagulation Induced by Low-temperature Plasma Treatment. Arch Biochem Biophys, 2016;605:95-101.

doi: 10.1016/j.abb.2016.03.023.

 

52.Wada N, Ikeda J, Nojima S, Tahara S, Ohshima K, Okuzaki D, Morii E. Requirement of CXCL12-CXCR7 signaling for CD20- CD138- double negative population in lymphoplasmacytic lymphoma. Lab Invest, 2016;96:517-525.

doi: 10.1038/labinvest.2016.28.

 

51. Ikehara S, Sakakita H, Ishikawa K, Yamaguchi T, Kim J, Ueda M, Ikeda J, Nakanishi H, Shimizu N, Hori M, Ikehara Y. Plasma blood coagulation without involving the activation of platelets and coagulation factors. Plasma Process Polym, 2015;12:1348-1353.

 

50. Ikeda J, Tsuruta Y, Nojima S, Sakakita H, Hori M, Ikehara Y. Anti-cancer effects of nonequilibrium atmospheric pressure plasma on cancer-initiating cells in human endometrioid adenocarcinoma cells. Plasma Process Polym, 2015;12:1370-1376.

DOI: 10.1002/ppap.201500097

 

49. Jokoji R, Ikeda J, Tsujimoto M, Morii E. Epithelioid Rhabdomyosarcoma; A case report with immunohistochemical and molecular study. Diagn Pathol, 2015;10(1):124.

doi: 10.1186/s13000-015-0349-2.

 

48. Zhan M, Ikeda JI, Wada N, Hori Y,  Nojima S, Tahara S, Ueda Y, Yoshino K, Kimura T, Morii E. Prognostic significance of a component of Hippo pathway, TAZ, in human endometrioid adenocarcinoma of uterus. Oncol Lett, 2016;11: 3611-3616.

 

47. Matsui T, Hori Y, Nagano H, Eguchi H, Marubashi S, Wada H, Wada N, Ikeda JI, Sakamoto M, Morii E. Poorly differentiated hepatocellular carcinoma accompanied by anti-Hu antibody-positive paraneoplastic peripheral neuropathy. Pathol Int, 2015;65(7):388-392.

doi: 10.1111/pin.12304.

 

46.Kakumoto K, Ikeda J, Okada M, Morii E, Oneyama C. mLST8 promotes mTOR-mediated tumor progression. PLoS ONE, 2015 Apr 23;10(4):e0119015 doi:10.1371/journal.pone.0119015. eCollection 2015.

 

45. Nishibayashi A, Kubo T, Matsuda K, Ikeda JI, Hosokawa K. Bronchogenic cyst in the chin region. J Dermatol, 2015;42(5):544-545.

doi: 10.1111/1346-8138.12816.

 

44.Ikeda J. Effect of non-equilibrium atmospheric pressure plasma on cancer initiating cells. Plasma Medicine, 2014;4(1-4):49-56

DOI: 10.1615/PlasmaMed.2014011935

 

43. Wang Y, Jiang Y, Ikeda J, Tian T, Sato A, Ohtsu H, Morii E . Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line. Cancer Med, 2014;3(5):1126-1135

doi: 10.1002/cam4.296.

 

42.Oneyama C, Kito Y, Asai R, Ikeda J, Yoshida T, Okuzaki D, Kokuda R, Kakumoto K, Takayama K, Inoue S, Morii E, Okada M. MiR-424/503-mediated Rictor upregulation promotes tumor progression. PLoS ONE, 2013 Nov 11;8(11):e80300. doi: 10.1371/journal.pone.0080300. eCollection 2013)

 

41.Wada N, Zhan M, Hori Y, Honma K, Ikeda JI, Morii E. Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line. Lab Invest, 2014;94(1):79-88

doi: 10.1038/labinvest.2013.129.

 

40.Wang Y, Jiang Y, Tian T, Hori Y, Wada N, Ikeda J, Morii E. Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma of uterus. Biochem Biophys Res Commun, 2013;440(4): 731-736

doi: 10.1016/j.bbrc.2013.09.139.

 

39.Ikeda J, Tian T, Wang Y, Hori Y, Honma K, Wada N, Morii E. Expression of FoxO3a in clinical cases of malignant lymphoma. Pathol Res Pract, 2013;209(11):716-720

doi: 10.1016/j.prp.2013.08.003.

 

38.Tian T, Ikeda JI, Wang Y, Mamat S, Luo W, Aozasa K, Morii E. Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumorigenesis in cancers. Eur J Cancer, 2012;48(15):2462-2473

doi: 10.1016/j.ejca.2012.01.018.

 

37.Mamat S, Ikeda J, Tian T, Wang Y, Luo W, Aozasa K, Morii E. Transcriptional regulation of aldehyde dehydrogenase 1A1 gene by alternative spliced forms of nuclear factor Y in tumorigenic population of endometrial adenocarcinoma. Genes Cancer 2011;2(10):979-984

doi: 10.1177/1947601911436009.

 

36.Ikeda J, Mamat S, Tian T, Wang Y, Luo W, Rahadiani N, Aozasa K, Morii E. Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells. Lab Invest 2012;92(4):606-614

doi: 10.1038/labinvest.2012.4.

 

35.Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Take H, Tsudo M, Morii E, Aozasa K. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch, 2011; 459(4):361-366

doi: 10.1007/s00428-011-1140-8.

 

34.Oneyama C, Morii E, Okuzaki D, Takahashi Y, Ikeda J, Wakabayashi N, Akamatsu H, Tsujimoto M, Nishida T, Aozasa K, Okada M. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene 2012;31(13):1623-1635

doi: 10.1038/onc.2011.367.

 

33.Wang Y, Ikeda J, Rahadiani N, Mamat S, Ueda Y, Tian T, Enomoto T, Kimura T, Aozasa K, Morii E. Prognostic significance of elongator protein 3 expression in endometrioid adenocarcinoma. Oncol Lett 2012;3:25-29

 

32.Fujita S, Morii E, Rahadiani N, Wada N, Hori Y, Ikeda J, Aozasa K. Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma. Exp Ther Med 2011;2:591-594.

 

31.Chihara T, Wada N, Ikeda J, Fujita S, Hori Y, Ogawa H, Sugiyama H, Nomura S, Matsumura I, Hino M, Kanakura Y, Morii E, Aozasa K. Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group. J Hematol Oncol 2011;4(1):14.

doi: 10.1186/1756-8722-4-14.

 

30.Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y, Morii E, Okumura M, Aozasa K, Okada M. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. Oncogene 2011;30:3489-3501

doi: 10.1038/onc.2011.63.

 

29.Zaki MA, Wada N, Kohara M, Ikeda J, Hori Y, Fujita S, Ogawa H, Sugiyama H, Hino M, Kanakura Y, Morii E, Aozasa K. Presence of B-cell clones in T-cell lymphoma. Eur J Haematol 2011;86:412-419

doi: 10.1111/j.1600-0609.2011.01597.x.

 

28.Rahadiani N, Ikeda JI, Mamat S, Matsuzaki S, Ueda Y, Umehara R, Tian T, Yi W, Enomoto T, Kimura T, Aozasa K, Mori E. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications. Cancer Sci 2011;102:903-908

doi: 10.1111/j.1349-7006.2011.01864.x.

 

27.Wada N, Ikeda J, Hori Y, Fujita S, Ogawa H, Soma T, Sugiyama H, Fukuhara S, Kanamaru A, Hino M, Kanakura Y, Morii E, Aozasa K. Epstein-Barr virus in diffuse large B-cell lymphoma in immunocompetent patients in Japan is as low as in Western countries. J Med Virol 2011;83(2):317-321

doi: 10.1002/jmv.21967.

 

26.Ikeda J, Mamat S, Tian T, Wang Y, Rahadiani N, Aozasa K, Morii E. Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines. Am J Pathol 2010;177(6):3081-3088

doi: 10.2353/ajpath.2010.100089.

 

25.Wada N, Kohara M, Ikeda J, Hori Y, Fujita S, Okada M, Ogawa M, Sugiyama H, Fukuhara S, Kanamaru A, Hino M, Kanakura Y, Morii E, Aozasa K. Diffuse large B-cell lymphoma in the spinal epidural space: A study of the Osaka Lymphoma Study Group. Pathol Res Pract 2010;206(7):439-444

doi: 10.1016/j.prp.2010.02.003.

 

24.Mamat S, Ikeda J, Enomoto T, Ueda Y, Rahadiani N, Tian T, Wang Y, Qiu Y, Kimura T, Aozasa K, Morii E. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma. Oncol Rep 2010;23(5):1221-1227

 

23.Rahadiani N, Ikeda JI, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg Oncol 2010;17(5):1311-1323

doi: 10.1245/s10434-009-0895-5.

 

22.Ikeda J, Yamauchi A, Hoshida Y, Okamura S, Hashimoto K, Aozasa K, Morii E. Peripheral T-cell lymphoma developing at ileocolonic anastomosis site after colectomy for adenocarcinoma. Pathol Res Pract 2010;206(6):376-378

doi: 10.1016/j.prp.2009.08.001.

 

21.Wada N, Ikeda J, Kohara M, Ogawa H, Hino M, Fukuhara S, Kanamaru A, Sugiyama H, Kanakura Y, Morii E, Aozasa K. Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group. Virchows Arch 2009; 455(3):285-93

doi: 10.1007/s00428-009-0827-6.

 

20.Oda T, Tian T, Inoue M, Ikeda JI, Qiu Y, Okumura M, Aozasa K, Morii E. Tumorigenic role of orphan nuclear receptor NROB1 in lung adenocarcinoma. Am J Pathol 2009; 175(3):1235-45

doi: 10.2353/ajpath.2009.090010.

 

19.Oda T, Morii E, Inoue M, Ikeda JI, Aozasa K, Okumura M. Prognostic significance of heat shock protein 105 in lung adenocarcinoma. Mol Med Reports 2009;2:603-607

doi: 10.3892/mmr_00000144.

 

18.Nakamichi I, Shimazu K, Ikeda J, Yamauchi A, Ishiko J, Mizuki M, Kanakura Y, Aozasa K. Intravascular lymphomatosis initially suspected from uterine cytology: a case report. Acta Cytol 2009;53(2):198-200

 

17.Nakamichi N, Morii E, Ikeda JI, Qiu Y, Mamat S, Tian T, FUkuhara S, Aozasa K. Synergistic effect of interleukin-6 and endoplasmic reticulum stress inducers on the high level of ABCG2 expression in plasma cells. Lab Invest 2009;89(3):327-336

doi: 10.1038/labinvest.2008.157.

 

16.Ikeda JI, Oda T, Inoue M, Uekita T, Sakai R, Okumura M, Aozasa K, Morii E. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 2009;100(3):429-433

doi: 10.1111/j.1349-7006.2008.01066.x.

 

15.Ikeda J, Morii E, Liu Y, Qiu Y, Nakamichi N, Jokoji R, Miyoshi Y, Noguchi S, Aozasa K. Prognostic significance of CD55 expression in breast cancer. Clin Cancer Res 2008; 14(15):4780-4786

doi: 10.1158/1078-0432.CCR-07-1844.

 

14.Yamauchi A, Ikeda J, Nakamichi I, Kohara M, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K. Diffuse large B-cell lymphoma showing an interfollicular pattern of proliferation: a study of the Osaka Lymphoma Study Group. Histopathology 2008;52(6):731-737

doi: 10.1111/j.1365-2559.2008.03018.x.

 

13.Kohmo S, Tachibana I, Osaki T, Goya S, Matsuoka H, Kijima T, Yoshida M, Kumagai T, Ikeda J, Aozasa K, Kawase I. Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung.

J Thorac Oncol 2007;2(11):1057-1059

 

12.Ikeda J, Morii E, Yamauchi A, Kohara M, Hashimoto N, Yoshikawa H, Iwasaki M, Aozasa K. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type developing in gonarthritis deformans.

J Clin Oncol 2007;25(27):4310-4312

 

11.Ch'ng ES, Hoshida Y, Iizuka N, Morii E, Ikeda JI, Yamamoto A, Tomita Y, Hanasaki H, Katsuya T, Maeda K, Ohishi M, Rakugi H, Ogihara T, Aozasa K. Composite malignant pheochromocytoma with malignant peripheral nerve sheath tumour: a case with 28 years of tumour-bearing history.

Histopathology 2007;51(3):420-422

 

10.Yamano T, Morii E, Ikeda J, Aozasa K. Granulocyte colony-stimulating factor production and rapid progression of gastric cancer after histological change in the tumor.

Jpn J Clin Oncol 2007;37(10):793-796

 

9.Yamauchi A, Fujita S, Ikeda J, Nakamichi I, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group.

Am J Hematol 2007;82:893-897

 

8.Xu JX, Morii E, Liu Y, Nakamichi N, Ikeda J, Kimura H, Aozasa K. High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells: high expression of CD55 as a novel character for side-population.

Exp Cell Res 2007;313:1877-1885

 

7.Ikeda J, Morii E, Tomita Y, Zhang B, Tokunaga T, Inoue M, Minami M, Okumura M, Aozasa K. Mediastinal lymphangiomatosis coexisting with occult thymic carcinoma.

Virchows Arch 2007;450:211-214

 

6.Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T, Aozasa K.Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.

J Rheumatol 2007;34:322-331

 

5.Ngan CY, Yamamoto H, Seshimo I, Tsujino T, Man-i M, Ikeda JI, Konishi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer.

Br J Cancer 2007;96:986-92

 

4.Kimura H, Morii E, Ikeda JI, Ezoe S, Xu JX, Nakamichi N, Tomita Y, Shibayama H, Kanakura Y, Aozasa K. Role of DNA methylation for expression of novel stem cell marker CDCP1 in hematopoietic cells.

Leukemia 2006;20:1551-1556

 

3.Ikeda JI, Morii E, Kimura H, Tomita Y, Takakuwa T, Hasegawa JI, Kim YK, Miyoshi Y, Noguchi S, Nishida T, Aozasa K. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.

J Pathol 2006;210:75-84    

 

2.Ikeda J, Morii E, Tomita Y, Xu JX, Kimura H, Kohara M, Hoshida Y, Aozasa K. Methotrexate-associated lymphoproliferative disorder mimicking composite lymphoma.

Int J Hematol 2006;83:363-5

 

1.Nishiu M, Tomita Y, Nakatsuka S, Takakuwa T, Iizuka N, Hoshida Y, Ikeda J, Iuchi K, Yanagawa R, Nakamura Y, Aozasa K. Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation.

Cancer Sci 2004;95:828-34

PageTop